Effects of androgen supplementation of hormone replacement therapy on the vascular reactivity of cerebral arteries

Maurio Penotti, Laura Sironi, Letizia Cannata, Paola Viganò, Andrea Casini, Livio Gabrielli, Mario Vignali

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Objective: To determine the effect of the androgen supplementation of hormone replacement therapy (HRT) on the vascular reactivity of cerebral arteries. Design: Open randomized study. Setting: Healthy volunteers in an academic research environment. Patient(s): Forty postmenopausal women who were treated with sequential HRT (transdermal E2 50 μg/d + medroxyprogesterone acetate 10 mg/d for 12 days every other month) for ≥1 year and ≤5 years. Intervention(s): Testosterone undecanoate (40 mg/d, p.o.) was randomly administered to 20 patients during ongoing HRT; the other 20 served as controls. Doppler evaluations of the internal carotid and middle cerebral arteries were performed together with lipid levels assessments. A visual analogue scale (VAS) was used to evaluate various parameters relating to sexual life and well-being. Main Outcome Measure(s): Pulsatility index (PI) of the arteries, VAS assessment of psychophysical well-being. Result(s): The administration of testosterone undecanoate during HRT induced an increase in the PI of the middle cerebral artery and a reduction of high-density lipoprotein cholesterol. Sexual desire and satisfaction were greatly improved. Conclusion(s): In postmenopausal women, androgen supplementation during HRT can partially counteract the beneficial effects of estrogens on cerebral vascular reactivity and lipid profiles, but sexual desire and satisfaction are greatly improved.

Original languageEnglish
Pages (from-to)235-240
Number of pages6
JournalFertility and Sterility
Volume76
Issue number2
DOIs
Publication statusPublished - 2001

Fingerprint

Cerebral Arteries
Hormone Replacement Therapy
Androgens
Blood Vessels
Orgasm
Middle Cerebral Artery
Visual Analog Scale
Lipids
Medroxyprogesterone Acetate
HDL Cholesterol
Healthy Volunteers
Estrogens
Arteries
Outcome Assessment (Health Care)
Research

Keywords

  • Androgen
  • HRT
  • Lipids
  • Menopause
  • Sexual behavior
  • Vascular reactivity

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Effects of androgen supplementation of hormone replacement therapy on the vascular reactivity of cerebral arteries. / Penotti, Maurio; Sironi, Laura; Cannata, Letizia; Viganò, Paola; Casini, Andrea; Gabrielli, Livio; Vignali, Mario.

In: Fertility and Sterility, Vol. 76, No. 2, 2001, p. 235-240.

Research output: Contribution to journalArticle

Penotti, Maurio ; Sironi, Laura ; Cannata, Letizia ; Viganò, Paola ; Casini, Andrea ; Gabrielli, Livio ; Vignali, Mario. / Effects of androgen supplementation of hormone replacement therapy on the vascular reactivity of cerebral arteries. In: Fertility and Sterility. 2001 ; Vol. 76, No. 2. pp. 235-240.
@article{33c5c912b27e4666b62c3ff9c71a8b8d,
title = "Effects of androgen supplementation of hormone replacement therapy on the vascular reactivity of cerebral arteries",
abstract = "Objective: To determine the effect of the androgen supplementation of hormone replacement therapy (HRT) on the vascular reactivity of cerebral arteries. Design: Open randomized study. Setting: Healthy volunteers in an academic research environment. Patient(s): Forty postmenopausal women who were treated with sequential HRT (transdermal E2 50 μg/d + medroxyprogesterone acetate 10 mg/d for 12 days every other month) for ≥1 year and ≤5 years. Intervention(s): Testosterone undecanoate (40 mg/d, p.o.) was randomly administered to 20 patients during ongoing HRT; the other 20 served as controls. Doppler evaluations of the internal carotid and middle cerebral arteries were performed together with lipid levels assessments. A visual analogue scale (VAS) was used to evaluate various parameters relating to sexual life and well-being. Main Outcome Measure(s): Pulsatility index (PI) of the arteries, VAS assessment of psychophysical well-being. Result(s): The administration of testosterone undecanoate during HRT induced an increase in the PI of the middle cerebral artery and a reduction of high-density lipoprotein cholesterol. Sexual desire and satisfaction were greatly improved. Conclusion(s): In postmenopausal women, androgen supplementation during HRT can partially counteract the beneficial effects of estrogens on cerebral vascular reactivity and lipid profiles, but sexual desire and satisfaction are greatly improved.",
keywords = "Androgen, HRT, Lipids, Menopause, Sexual behavior, Vascular reactivity",
author = "Maurio Penotti and Laura Sironi and Letizia Cannata and Paola Vigan{\`o} and Andrea Casini and Livio Gabrielli and Mario Vignali",
year = "2001",
doi = "10.1016/S0015-0282(01)01923-9",
language = "English",
volume = "76",
pages = "235--240",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Effects of androgen supplementation of hormone replacement therapy on the vascular reactivity of cerebral arteries

AU - Penotti, Maurio

AU - Sironi, Laura

AU - Cannata, Letizia

AU - Viganò, Paola

AU - Casini, Andrea

AU - Gabrielli, Livio

AU - Vignali, Mario

PY - 2001

Y1 - 2001

N2 - Objective: To determine the effect of the androgen supplementation of hormone replacement therapy (HRT) on the vascular reactivity of cerebral arteries. Design: Open randomized study. Setting: Healthy volunteers in an academic research environment. Patient(s): Forty postmenopausal women who were treated with sequential HRT (transdermal E2 50 μg/d + medroxyprogesterone acetate 10 mg/d for 12 days every other month) for ≥1 year and ≤5 years. Intervention(s): Testosterone undecanoate (40 mg/d, p.o.) was randomly administered to 20 patients during ongoing HRT; the other 20 served as controls. Doppler evaluations of the internal carotid and middle cerebral arteries were performed together with lipid levels assessments. A visual analogue scale (VAS) was used to evaluate various parameters relating to sexual life and well-being. Main Outcome Measure(s): Pulsatility index (PI) of the arteries, VAS assessment of psychophysical well-being. Result(s): The administration of testosterone undecanoate during HRT induced an increase in the PI of the middle cerebral artery and a reduction of high-density lipoprotein cholesterol. Sexual desire and satisfaction were greatly improved. Conclusion(s): In postmenopausal women, androgen supplementation during HRT can partially counteract the beneficial effects of estrogens on cerebral vascular reactivity and lipid profiles, but sexual desire and satisfaction are greatly improved.

AB - Objective: To determine the effect of the androgen supplementation of hormone replacement therapy (HRT) on the vascular reactivity of cerebral arteries. Design: Open randomized study. Setting: Healthy volunteers in an academic research environment. Patient(s): Forty postmenopausal women who were treated with sequential HRT (transdermal E2 50 μg/d + medroxyprogesterone acetate 10 mg/d for 12 days every other month) for ≥1 year and ≤5 years. Intervention(s): Testosterone undecanoate (40 mg/d, p.o.) was randomly administered to 20 patients during ongoing HRT; the other 20 served as controls. Doppler evaluations of the internal carotid and middle cerebral arteries were performed together with lipid levels assessments. A visual analogue scale (VAS) was used to evaluate various parameters relating to sexual life and well-being. Main Outcome Measure(s): Pulsatility index (PI) of the arteries, VAS assessment of psychophysical well-being. Result(s): The administration of testosterone undecanoate during HRT induced an increase in the PI of the middle cerebral artery and a reduction of high-density lipoprotein cholesterol. Sexual desire and satisfaction were greatly improved. Conclusion(s): In postmenopausal women, androgen supplementation during HRT can partially counteract the beneficial effects of estrogens on cerebral vascular reactivity and lipid profiles, but sexual desire and satisfaction are greatly improved.

KW - Androgen

KW - HRT

KW - Lipids

KW - Menopause

KW - Sexual behavior

KW - Vascular reactivity

UR - http://www.scopus.com/inward/record.url?scp=0034899879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034899879&partnerID=8YFLogxK

U2 - 10.1016/S0015-0282(01)01923-9

DO - 10.1016/S0015-0282(01)01923-9

M3 - Article

VL - 76

SP - 235

EP - 240

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 2

ER -